Canada Pharmaceutical Market Size, Share & Trends Analysis Report By Drug Type, By Product, By Type, By Disease, By Route of Administration, By Formulation, By Age Group, By End-use, And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Canada Pharmaceutical Market: Methodology and Scope
                    1.1. Market Segmentation and Scope
                        1.1.1. Segment Definitions
                            1.1.1.1. Drug Type Segment
                            1.1.1.2. Product Segment
                            1.1.1.3. Type Segment
                            1.1.1.4. Disease Segment
                            1.1.1.5. Route Of Administration Segment
                            1.1.1.6. Formulation Segment
                            1.1.1.7. Age Group Segment
                            1.1.1.8. End-use Segment
                    1.2. Estimates and Forecast Timeline
                    1.3. Objectives
                        1.3.1. Objective - 1
                        1.3.2. Objective - 2
                        1.3.3. Objective - 3
                    1.4. Research Methodology
                    1.5. Information Procurement
                        1.5.1. Purchased Database
                        1.5.2. GVR’s Internal Database
                        1.5.3. Secondary Sources
                        1.5.4. Primary Research
                    1.6. Information or Data Analysis
                        1.6.1. Data Analysis Models
                    1.7. Market Formulation & Validation
                    1.8. Model Details
                        1.8.1. Commodity Flow Analysis
                    1.9. List of Secondary Sources
                    1.10. List of Abbreviations
Chapter 2. Canada Pharmaceutical Market: Executive Summary
                    2.1. Market Snapshot
                    2.2. Drug Type and Product Snapshot
                    2.3. Type and Disease Snapshot
                    2.4. Route Of Administration and Formulation Snapshot
                    2.5. Age Group, and End-use Snapshot
                    2.6. Competitive Landscape Snapshot
Chapter 3. Canada Pharmaceutical Market Variables, Trends, & Scope
                    3.1. Market Segmentation and Scope
                    3.2. Market Lineage Outlook
                        3.2.1. Parent Market Outlook
                        3.2.2. Related/Ancillary Market Outlook
                    3.3. Market Dynamics
                    3.4. Market Drivers Analysis
                        3.4.1. Rise in pharmaceutical R&D spending
                        3.4.2. Rise in focus toward healthcare needs
                        3.4.3. Technological advancements
                        3.4.4. Increase in geriatric population and incidence of chronic disorders
                    3.5. Market Restraint Analysis
                        3.5.1. Patent expiration of most profitable drugs
                        3.5.2. Pricing pressures on bio/pharmaceutical companies
                    3.6. Porter’s Five Forces Analysis
                    3.7. PESTLE Analysis
Chapter 4. Canada Pharmaceutical Market: Drug Type Estimates & Trends Analysis
                    4.1. Canada Pharmaceutical Market: Drug Type Movement Analysis
                    4.2. Biologics & Biosimilars (Large Molecules)
                        4.2.1. Biologics & Biosimilars Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                        4.2.2. Monoclonal Antibodies
                            4.2.2.1. Monoclonal Antibodies Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                        4.2.3. Vaccines
                            4.2.3.1. Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                        4.2.4. Cell & Gene Therapy
                            4.2.4.1. Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                        4.2.5. Others
                            4.2.5.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    4.3. Conventional Drugs (Small Molecules)
                        4.3.1. Conventional Drugs (Small Molecules) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 5. Canada Pharmaceutical Market: Product Estimates & Trends Analysis
                    5.1. Canada Pharmaceutical Market: Product Movement Analysis
                    5.2. Branded
                        5.2.1. Branded Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    5.3. Generics
                        5.3.1. Generics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 6. Canada Pharmaceutical Market: Type Estimates & Trends Analysis
                    6.1. Canada Pharmaceutical Market: Type Movement Analysis
                    6.2. Prescription
                        6.2.1. Prescription Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    6.3. OTC
                        6.3.1. OTC Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 7. Canada Pharmaceutical Market: Disease Estimates & Trends Analysis
                    7.1. Canada Pharmaceutical Market: Type Movement Analysis
                    7.2. Cardiovascular diseases
                        7.2.1. Cardiovascular diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    7.3. Cancer
                        7.3.1. Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    7.4. Diabetes
                        7.4.1. Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    7.5. Infectious Disease
                        7.5.1. Infections Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    7.6. Neurological Disorders
                        7.6.1. Neurological Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    7.7. Respiratory Diseases
                        7.7.1. Respiratory Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    7.8. Autoimmune Diseases
                        7.8.1. Autoimmune Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    7.9. Mental Health Disorders
                        7.9.1. Mental Health Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    7.10. Gastrointestinal Disorders
                        7.10.1. Gastrointestinal Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    7.11. Women’s Health Diseases
                        7.11.1. Women’s Health Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    7.12. Genetic and Rare genetic Diseases
                        7.12.1. Genetic and Rare genetic Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    7.13. Dermatological Conditions
                        7.13.1. Dermatological Conditions Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    7.14. Obesity
                        7.14.1. Obesity Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    7.15. Renal Diseases
                        7.15.1. Renal Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    7.16. Liver Conditions
                        7.16.1. Liver Conditions Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    7.17. Hematological Disorders
                        7.17.1. Hematological Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    7.18. Eye Conditions
                        7.18.1. Eye Conditions Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    7.19. Endocrine Disorders
                        7.19.1. Endocrine Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    7.20. Allergies
                        7.20.1. Allergies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    7.21. Others
                        7.21.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 8. Canada Pharmaceutical Market: Route of Administration Estimates & Trends Analysis
                    8.1. Canada Pharmaceutical Market: Route of Administration Movement Analysis
                    8.2. Oral
                        8.2.1. Oral Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    8.3. Topical
                        8.3.1. Topical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    8.4. Parenteral
                        8.4.1. Parenteral Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                        8.4.2. Intravenous
                            8.4.2.1. Intravenous Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                        8.4.3. Intramuscular
                            8.4.3.1. Intramuscular Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    8.5. Inhalations
                        8.5.1. Inhalations Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    8.6. Others
                        8.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 9. Canada Pharmaceutical Market: Formulation Estimates & Trends Analysis
                    9.1. Canada Pharmaceutical Market: Formulation Movement Analysis
                    9.2. Tablets
                        9.2.1. Tablets Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    9.3. Capsules
                        9.3.1. Capsules Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    9.4. Injectable
                        9.4.1. Injectable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    9.5. Sprays
                        9.5.1. Sprays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    9.6. Suspensions
                        9.6.1. Suspensions Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    9.7. Powders
                        9.7.1. Powders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    9.8. Others
                        9.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 10. Canada Pharmaceutical Market: Age Group Estimates & Trends Analysis
                    10.1. Canada Pharmaceutical Market: Age Group Movement Analysis
                    10.2. Children & Adolescents
                        10.2.1. Children & Adolescents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    10.3. Adults
                        10.3.1. Adults Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    10.4. Geriatric
                        10.4.1. Geriatric Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 11. Canada Pharmaceutical Market: End-use Estimates & Trends Analysis
                    11.1. Canada Pharmaceutical Market: End-User Movement Analysis
                    11.2. Hospitals
                        11.2.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    11.3. Clinics
                        11.3.1. Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    11.4. Others
                        11.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 12. Canada Pharmaceutical Market: Country Business Analysis
                        12.1.1. CANADA
                            12.1.1.1. Canada Pharmaceutical Market, 2018 - 2030 (USD Billion)
                            12.1.1.2. Key Country Dynamics
                            12.1.1.3. Regulatory Framework
                            12.1.1.4. Reimbursement Scenario
                            12.1.1.5. Competitive Scenario
Chapter 13. Canada Pharmaceutical Market: Competitive Landscape
                    13.1. Company Categorization
                    13.2. Strategy Mapping
                        13.2.1. New Product Type Launch
                        13.2.2. Partnerships
                        13.2.3. Acquisition
                        13.2.4. Collaboration
                        13.2.5. Funding
                    13.3. Key Company Market Share Analysis, 2023
                    13.4. Company Heat Map Analysis
                    13.5. Company Profiles
                        13.5.1. F. Hoffmann-La Roche Ltd.
                            13.5.1.1. Company Overview
                            13.5.1.2. Financial Performance
                            13.5.1.3. Product Benchmarking
                            13.5.1.4. Strategic Initiatives
                        13.5.2. Novartis AG
                            13.5.2.1. Company Overview
                            13.5.2.2. Financial Performance
                            13.5.2.3. Product Benchmarking
                            13.5.2.4. Strategic Initiatives
                        13.5.3. GlaxoSmithKline plc
                            13.5.3.1. Company Overview
                            13.5.3.2. Financial Performance
                            13.5.3.3. Product Benchmarking
                            13.5.3.4. Strategic Initiatives
                        13.5.4. Pfizer, Inc.
                            13.5.4.1. Company Overview
                            13.5.4.2. Financial Performance
                            13.5.4.3. Product Benchmarking
                            13.5.4.4. Strategic Initiatives
                        13.5.5. Merck & Co., Inc.
                            13.5.5.1. Company Overview
                            13.5.5.2. Financial Performance
                            13.5.5.3. Product Benchmarking
                            13.5.5.4. Strategic Initiatives
                        13.5.6. AstraZeneca
                            13.5.6.1. Company Overview
                            13.5.6.2. Product Benchmarking
                            13.5.6.3. Strategic Initiatives
                        13.5.7. Johnson & Johnson Services, Inc.
                            13.5.7.1. Company Overview
                            13.5.7.2. Product Benchmarking
                            13.5.7.3. Strategic Initiatives
                        13.5.8. Sanofi
                            13.5.8.1. Company Overview
                            13.5.8.2. Financial Performance
                            13.5.8.3. Product Benchmarking
                            13.5.8.4. Strategic Initiatives
                        13.5.9. Eli Lilly and Company
                            13.5.9.1. Company Overview
                            13.5.9.2. Financial Performance
                            13.5.9.3. Product Benchmarking
                            13.5.9.4. Strategic Initiatives
                        13.5.10. AbbVie, Inc.
                            13.5.10.1. Company Overview
                            13.5.10.2. Financial Performance
                            13.5.10.3. Product Benchmarking
                            13.5.10.4. Strategic Initiatives

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviation
Table 3 Canada pharmaceutical market, by drug type, 2018 - 2030 (USD Billion)
Table 4 Canada pharmaceutical market, by product, 2018 - 2030 (USD Billion)
Table 5 Canada pharmaceutical market, by type, 2018 - 2030 (USD Billion)
Table 6 Canada pharmaceutical market, by disease, 2018 - 2030 (USD Billion)
Table 7 Canada pharmaceutical market, by route of administration, 2018 - 2030 (USD Billion)
Table 8 Canada pharmaceutical market, by formulation, 2018 - 2030 (USD Billion)
Table 9 Canada pharmaceutical market, by age group, 2018 - 2030 (USD Billion)
Table 10 Canada pharmaceutical market, by end-use, 2018 - 2030 (USD Billion)

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Market summary
Fig. 4 Market segmentation & scope
Fig. 5 Market size and growth prospects
Fig. 6 Canada pharmaceutical market- Key market driver analysis
Fig. 7 Canada pharmaceutical market - Key market restraint analysis
Fig. 8 Penetration & growth prospect mapping
Fig. 9 Canada pharmaceutical market - Porter’s analysis
Fig. 10 Canada pharmaceutical market - PESTEL analysis
Fig. 11 Canada pharmaceutical market drug type outlook key takeaways
Fig. 12 Canada pharmaceutical market: Drug type movement analysis
Fig. 13 Biologics & Biosimilars (Large Molecules) market estimates, 2018 - 2030 (USD Billion)
Fig. 14 Monoclonal antibodies market estimates, 2018 - 2030 (USD Billion)
Fig. 15 Vaccines market estimates, 2018 - 2030 (USD Billion)
Fig. 16 Cell & gene therapy market estimates, 2018 - 2030 (USD Billion)
Fig. 17 Others market estimates, 2018 - 2030 (USD Billion)
Fig. 18 Conventional drugs (Small Molecules) market estimates, 2018 - 2030 (USD Billion)
Fig. 19 Canada pharmaceutical market product outlook key takeaways
Fig. 20 Canada pharmaceutical market: Product movement analysis
Fig. 21 Branded market estimates, 2018 - 2030 (USD Billion)
Fig. 22 Generics market estimates, 2018 - 2030 (USD Billion)
Fig. 23 Canada pharmaceutical market type outlook key takeaways
Fig. 24 Canada pharmaceutical market: Type movement analysis
Fig. 25 Prescription market estimates, 2018 - 2030 (USD Billion)
Fig. 26 OTC market estimates, 2018 - 2030 (USD Billion)
Fig. 27 Canada pharmaceutical market disease outlook key takeaways
Fig. 28 Canada pharmaceutical market: Disease movement analysis
Fig. 29 Cardiovascular diseases market estimates, 2018 - 2030 (USD Billion)
Fig. 30 Cancer market estimates, 2018 - 2030 (USD Billion)
Fig. 31 Diabetes market estimates, 2018 - 2030 (USD Billion)
Fig. 32 Infectious diseases market estimates, 2018 - 2030 (USD Billion)
Fig. 33 Neurological disorders market estimates, 2018 - 2030 (USD Billion)
Fig. 34 Respiratory diseases market estimates, 2018 - 2030 (USD Billion)
Fig. 35 Autoimmune diseases market estimates, 2018 - 2030 (USD Billion)
Fig. 36 Mental health disorders market estimates, 2018 - 2030 (USD Billion)
Fig. 37 Gastrointestinal disorders market estimates, 2018 - 2030 (USD Billion)
Fig. 38 Women’s Health Diseases market estimates, 2018 - 2030 (USD Billion)
Fig. 39 Genetic and Rare genetic diseases market estimates, 2018 - 2030 (USD Billion)
Fig. 40 Dermatological conditions market estimates, 2018 - 2030 (USD Billion)
Fig. 41 Obesity market estimates, 2018 - 2030 (USD Billion)
Fig. 42 Renal diseases market estimates, 2018 - 2030 (USD Billion)
Fig. 43 Liver conditions market estimates, 2018 - 2030 (USD Billion)
Fig. 44 Hematological disorders market estimates, 2018 - 2030 (USD Billion)
Fig. 45 Eye conditions market estimates, 2018 - 2030 (USD Billion)
Fig. 46 Infertility conditions market estimates, 2018 - 2030 (USD Billion)
Fig. 47 Endocrine disorders market estimates, 2018 - 2030 (USD Billion)
Fig. 48 Allergies market estimates, 2018 - 2030 (USD Billion)
Fig. 49 Others market estimates, 2018 - 2030 (USD Billion)
Fig. 50 Canada pharmaceutical market route of administration outlook key takeaways
Fig. 51 Canada pharmaceutical market: Route of administration movement analysis
Fig. 52 Oral market estimates, 2018 - 2030 (USD Billion)
Fig. 53 Topical market estimates, 2018 - 2030 (USD Billion)
Fig. 54 Diabetes market estimates, 2018 - 2030 (USD Billion)
Fig. 55 Parenteral market estimates, 2018 - 2030 (USD Billion)
Fig. 56 Intravenous market estimates, 2018 - 2030 (USD Billion)
Fig. 57 Intramuscular market estimates, 2018 - 2030 (USD Billion)
Fig. 58 Inhalations market estimates, 2018 - 2030 (USD Billion)
Fig. 59 Other routes of administration market estimates, 2018 - 2030 (USD Billion)
Fig. 60 Canada pharmaceutical market formulation outlook key takeaways
Fig. 61 Canada pharmaceutical market: Formulation movement analysis
Fig. 62 Tablets market estimates, 2018 - 2030 (USD Billion)
Fig. 63 Capsules market estimates, 2018 - 2030 (USD Billion)
Fig. 64 Injectable market estimates, 2018 - 2030 (USD Billion)
Fig. 65 Sprays market estimates, 2018 - 2030 (USD Billion)
Fig. 66 Suspensions market estimates, 2018 - 2030 (USD Billion)
Fig. 67 Powders market estimates, 2018 - 2030 (USD Billion)
Fig. 68 Other formulations market estimates, 2018 - 2030 (USD Billion)
Fig. 69 Canada pharmaceutical market age group outlook key takeaways
Fig. 70 Canada pharmaceutical market: Age Group movement analysis
Fig. 71 Children & adolescents market estimates, 2018 - 2030 (USD Billion)
Fig. 72 Adults market estimates, 2018 - 2030 (USD Billion)
Fig. 73 Geriatric market estimates, 2018 - 2030 (USD Billion)
Fig. 74 Canada pharmaceutical market end-user outlook key takeaways
Fig. 75 Canada pharmaceutical market: End-use movement analysis
Fig. 76 Hospitals market estimates, 2018 - 2030 (USD Billion)
Fig. 77 Clinics market estimates, 2018 - 2030 (USD Billion)
Fig. 78 Others market estimates, 2018 - 2030 (USD Billion)
Fig. 79 Country marketplace: Key takeaways
Fig. 80 Canada pharmaceutical market: Country movement analysis
Fig. 81 Canada pharmaceutical market, 2018 - 2030 (USD Billion)
Fig. 82 Strategy framework